Jury Awards $4.62B in Johnson & Johnson Talcum Powder Lawsuit

The award includes $550 million in compensatory damages and $4.14 billion in punitive damages

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

FRIDAY, July 13, 2018 (HealthDay News) -- A jury says Johnson & Johnson must pay $4.62 billion to 22 women who allege they developed ovarian cancer after using the company's Baby Powder and Shower to Shower brand talcum powder as part of their daily feminine hygiene routine.

The St. Louis jury announced their decision July 12 after weeks of hearing testimony and eight hours of deliberation. The award includes $550 million in compensatory damages and $4.14 billion in punitive damages, CNN reported. It's the largest such verdict against the company, which plans to file an appeal.

"Every verdict against Johnson & Johnson in this court that has gone through the appeals process has been reversed and the multiple errors present in this trial were worse than those in the prior trials which have been reversed," the company said in an official statement.

Johnson & Johnson faces thousands of similar lawsuits nationwide. Favorable verdicts have been awarded to plaintiffs in five of the cases, but those cases are in various stages of appeal, CNN reported.

More Information - AP News
More Information - American Cancer Society

Last Updated: